Viewing Study NCT01513460


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-05-21 @ 2:49 PM
Study NCT ID: NCT01513460
Status: COMPLETED
Last Update Posted: 2015-01-05
First Post: 2012-01-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Obstructive Pulmonary Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Obstructive Pulmonary Disease, View
None NVA 237, View
None glycopyrronium, View
None COPD View